Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies Profit Margin 2013-2019 | ITCI

Current and historical gross margin, operating margin and net profit margin for Intra-Cellular Therapies (ITCI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Intra-Cellular Therapies net profit margin as of September 30, 2019 is 0%.
  
Intra-Cellular Therapies Annual Profit Margins
Intra-Cellular Therapies Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.489B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.829B 14.96
CSL (CSLLY) Australia $82.928B 0.00
Gilead Sciences (GILD) United States $80.729B 10.00
Celgene (CELG) United States $78.303B 11.18
Vertex Pharmaceuticals (VRTX) United States $52.716B 53.81
Biogen (BIIB) United States $49.649B 8.52
Illumina (ILMN) United States $43.871B 48.13
Regeneron Pharmaceuticals (REGN) United States $37.153B 16.27
Alexion Pharmaceuticals (ALXN) United States $23.432B 11.57
Seattle Genetics (SGEN) United States $19.416B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
Incyte (INCY) United States $18.479B 42.90
BioMarin Pharmaceutical (BMRN) United States $13.576B 0.00
Genmab (GNMSF) Denmark $13.448B 59.40
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Exact Sciences (EXAS) United States $10.288B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.085B 0.00
Galapagos (GLPG) Belgium $10.076B 25.96
BeiGene (BGNE) Cayman Islands $9.325B 0.00
QIAGEN (QGEN) Netherlands $8.407B 27.41
Bio-Techne Corp (TECH) United States $7.759B 51.93
Amarin (AMRN) Ireland $7.677B 0.00
Guardant Health (GH) United States $7.264B 0.00
Sarepta Therapeutics (SRPT) United States $7.261B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.004B 0.00
Reata Pharmaceuticals (RETA) United States $6.125B 0.00
Moderna (MRNA) United States $6.112B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.583B 14.19
ARGENX SE-ADR (ARGX) Netherlands $5.236B 0.00
Exelixis (EXEL) United States $5.062B 14.24
Ascendis Pharma (ASND) Denmark $4.702B 0.00
China Biologic Products (CBPO) China $4.594B 25.88
Spark Therapeutics (ONCE) United States $4.269B 0.00
Repligen (RGEN) United States $4.252B 77.06
Bluebird Bio (BLUE) United States $4.081B 0.00
Mirati Therapeutics (MRTX) United States $4.069B 0.00
Medicines (MDCO) United States $4.057B 0.00
Blueprint Medicines (BPMC) United States $3.547B 0.00
Adaptive Biotechnologies (ADPT) United States $3.393B 0.00
Immunomedics (IMMU) United States $3.345B 0.00
MorphoSys AG (MOR) Germany $3.294B 0.00
Alkermes (ALKS) Ireland $3.139B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.040B 0.00
Genmab (GMAB) Denmark $2.840B 5.85
Emergent Biosolutions (EBS) United States $2.806B 27.87
Intercept Pharmaceuticals (ICPT) United States $2.718B 0.00
Halozyme Therapeutics (HALO) United States $2.710B 0.00
NeoGenomics (NEO) United States $2.451B 130.44
MyoKardia (MYOK) United States $2.419B 0.00
Amicus Therapeutics (FOLD) United States $2.382B 0.00
UniQure (QURE) Netherlands $2.293B 0.00
Acceleron Pharma (XLRN) United States $2.282B 0.00
Arena Pharmaceuticals (ARNA) United States $2.276B 5.29
Zai Lab (ZLAB) China $2.262B 0.00
RA PHARMCTL INC (RARX) United States $2.197B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.125B 0.00
Cambrex (CBM) United States $2.019B 25.47
Ligand Pharmaceuticals (LGND) United States $1.841B 35.41
Myriad Genetics (MYGN) United States $1.823B 26.93
Akcea Therapeutics (AKCA) United States $1.794B 0.00
Insmed (INSM) United States $1.716B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.588B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.460B 0.00
Denali Therapeutics (DNLI) United States $1.440B 0.00
Zymeworks (ZYME) Canada $1.417B 0.00
Epizyme (EPZM) United States $1.390B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.380B 0.00
REGENXBIO (RGNX) United States $1.337B 0.00
Coherus BioSciences (CHRS) United States $1.331B 0.00
Innoviva (INVA) United States $1.235B 3.64
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Editas Medicine (EDIT) United States $1.163B 0.00
Sangamo Therapeutics (SGMO) United States $1.096B 0.00
Alector (ALEC) United States $1.069B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $1.060B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.031B 0.00
Arvinas (ARVN) United States $1.014B 0.00
Principia Biopharma (PRNB) United States $1.004B 0.00
WAVE Life Sciences (WVE) Singapore $0.956B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.888B 0.00
Codexis (CDXS) United States $0.878B 0.00
Athenex (ATNX) United States $0.870B 0.00
Cara Therapeutics (CARA) United States $0.858B 0.00
Anika Therapeutics (ANIK) United States $0.853B 27.67
Vericel (VCEL) United States $0.829B 309.00
Vanda Pharmaceuticals (VNDA) United States $0.826B 6.95
ZIOPHARM Oncology Inc (ZIOP) United States $0.795B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.711B 181.72
Twist Bioscience (TWST) United States $0.700B 0.00
Revance Therapeutics (RVNC) United States $0.685B 0.00
DBV Technologies S.A (DBVT) France $0.675B 0.00
ANI Pharmaceuticals (ANIP) United States $0.673B 11.47
Intellia Therapeutics (NTLA) United States $0.661B 0.00
MiMedx (MDXG) United States $0.650B 0.00
Mesoblast (MESO) Australia $0.600B 0.00
Precision BioSciences (DTIL) United States $0.599B 0.00
Adverum Biotechnologies (ADVM) United States $0.582B 0.00
Cellectis S.A (CLLS) France $0.581B 0.00
GENFIT S.A (GNFT) France $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.558B 0.00
Retrophin (RTRX) United States $0.555B 0.00
UROGEN PHARMA (URGN) United States $0.550B 0.00
Agenus (AGEN) United States $0.514B 0.00
Kadmon Holdings (KDMN) United States $0.508B 0.00
Dynavax Technologies (DVAX) United States $0.489B 0.00
Cytokineticsorporated (CYTK) United States $0.479B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Stemline Therapeutics (STML) United States $0.475B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
AC Immune SA (ACIU) Switzerland $0.464B 10.73
Sinovac Biotech (SVA) China $0.460B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.448B 0.00
PHARMA MAR SA (PHMMF) Spain $0.432B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Arcus Biosciences (RCUS) United States $0.366B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.363B 2.51
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Clovis Oncology (CLVS) United States $0.346B 0.00
Bellus Health (BLU) Canada $0.339B 0.00
PDL BioPharma (PDLI) United States $0.338B 8.46
AMAG Pharmaceuticals (AMAG) United States $0.334B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.312B 0.00
Kindred Biosciences (KIN) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.295B 0.00
Avid Bioservices (CDMO) United States $0.295B 0.00
Protagonist Therapeutics (PTGX) United States $0.294B 0.00
Compugen (CGEN) Israel $0.285B 0.00
Theratechnologies (THTX) Canada $0.279B 0.00
Geron (GERN) United States $0.274B 0.00
Seres Therapeutics (MCRB) United States $0.260B 0.00
Gritstone Oncology (GRTS) United States $0.256B 0.00
Sutro Biopharma (STRO) United States $0.250B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.00
CytomX Therapeutics (CTMX) United States $0.244B 0.00
MannKind (MNKD) United States $0.244B 0.00
Scholar Rock Holding (SRRK) United States $0.243B 0.00
ADMA Biologics Inc (ADMA) United States $0.240B 0.00
Kamada (KMDA) Israel $0.240B 7.01
Albireo Pharma (ALBO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Syros Pharmaceuticals (SYRS) United States $0.221B 0.00
Inovio Pharmaceuticals (INO) United States $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Athersys (ATHX) United States $0.212B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.211B 0.00
Sorrento Therapeutics (SRNE) United States $0.211B 0.00
Exicure (XCUR) United States $0.208B 0.00
OSMOTICA PHARM (OSMT) United States $0.207B 0.00
Cue Biopharma (CUE) United States $0.207B 0.00
Spero Therapeutics (SPRO) United States $0.196B 0.00
Affimed (AFMD) Germany $0.185B 0.00
ChromaDex (CDXC) United States $0.184B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.183B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.166B 0.00
Dyadic (DYAI) United States $0.163B 0.00
Senesco Technologies (ELOX) United States $0.162B 0.00
Arsanis (XFOR) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.154B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Alcobra (ARCT) United States $0.146B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
Cerecor (CERC) United States $0.133B 0.00
Five Prime Therapeutics (FPRX) United States $0.133B 0.00
Enzo Biochem (ENZ) United States $0.133B 0.00
Prometic Life Sciences (PFSCF) Canada $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Ophthotech (ISEE) United States $0.132B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Mersana Therapeutics (MRSN) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Fortress Biotech (FBIO) United States $0.117B 0.00
Abeona Therapeutics (ABEO) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Novavax (NVAX) United States $0.112B 0.00
NantKwest (NK) United States $0.110B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
OvaScience (MLND) United States $0.104B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.091B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Arbutus Biopharma (ABUS) Canada $0.087B 0.00
Celyad SA (CYAD) Belgium $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Strongbridge Biopharma (SBBP) United States $0.085B 2.26
VTv Therapeutics (VTVT) United States $0.084B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.084B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Verastem (VSTM) United States $0.070B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
Orgenesis (ORGS) United States $0.048B 3.13
AquaBounty Technologies (AQB) United States $0.047B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.039B 0.00
Evogene (EVGN) Israel $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Unum Therapeutics (UMRX) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.93
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
VistaGen Therapeutics (VTGN) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.002B 0.00